|
tbar.gif
Click
here to
submit entries
|
|
|
Illumina
Reorganization Embraces Molecular Diagnostics |
January
4, 2008--Illumina has reorganized
its operating structure to further leverage the synergies between its
sequencing and genotyping businesses. A newly created Life Sciences
Business Unit will include all products and services related to the
research market. The company has also created a Diagnostics Business Unit
to put more focus on the emerging opportunity in molecular diagnostics. Illumina
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
